beta
Text
1. Defendant A shall be punished by imprisonment with prison labor for one year and eight months;
2. Defendant B shall be punished by imprisonment with prison labor for not less than ten months.
(b).
Reasons
Punishment of the crime
1. Defendant A, Defendant C, Defendant B, and Defendant D are the representative director of Company E who manufactures drugs after obtaining marketing approval of drugs from around 2005 and has overall control over the overall business affairs of the company, such as marketing of drugs. Defendant C is the head of the headquarters of the business affairs of Company E, the head of the headquarters of the company E, who exercises overall control over the overall business affairs of the company. Defendant B is the head of the headquarters of the business affairs of Company E, who takes overall control over the accounting affairs, such as the raising of rebates funds, personnel affairs, planning affairs, and who takes overall control over the business affairs of the headquarters. Defendant D is the head of the headquarters
On January 1, 2010, Defendants would like to increase sales by providing economic benefits for the prescription of drugs manufactured and sold in the E office against the intent of customers Byung, etc., Defendant B, as above, intended to take charge of the role of examining the appropriateness of the economic benefits provided to doctors, etc. by the business employees of the E company. Defendant C, while managing the above business employees, intended to take charge of the role of calculating the money to be provided to doctors, etc. and paying them to the above business employees.
(a) No person who has obtained marketing approval of a drug in violation of the Pharmaceutical Affairs Act shall provide money, goods, benefits, labor, entertainment, or other economic benefits to a medical person, founder of a medical institution, or any employee of a medical institution for the purpose of sales promotion, such as adoption of, guidance for prescription of, etc.
On March 201, the Defendants provided economic benefits, such as cash, by prescribing AK, which is manufactured and sold in E, in a treatment room operated by AH in PG in PG in PG in Busan City, through AJ of Busan business employees in PP of the corporation E.
“ subject to an offer.”